New personalized vaccine shows promise in brain cancer fight
NCT ID NCT07365280
First seen Jan 27, 2026 · Last updated Apr 25, 2026 · Updated 15 times
Summary
This study tests a personalized vaccine (ZSNeo-DC1.1) made from a patient's own immune cells, combined with standard chemotherapy (temozolomide), for people with newly diagnosed glioblastoma, a serious brain cancer. The goal is to see if the vaccine can help control the cancer and extend life. About 78 participants will be randomly assigned to receive either the vaccine plus chemotherapy or chemotherapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.